Correlation of p53 immunoexpression with DNA ploidy and apoptotic index in subsets of prostate cancer: A marker reiterated in progression and recurrence of prostate cancer

South Asian Journal of Cancer

Volumn 4, Issue 2, 2015, Pages 88-90

  Bansal, Anju ^a   Gupta, Anup ^a   Saxena, Sunita ^a  

^a SAFDARJUNG HOSPITAL   (India)

Author keywords

p53; prostate cancer; prostatic intraepithelial neoplasia

Indexed keywords

DNA; PROTEIN P53;

ANEUPLOIDY; APOPTOSIS; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CONFERENCE PAPER; CONTROLLED STUDY; FLOW CYTOMETRY; GLEASON SCORE; HORMONE SENSITIVITY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION;

EID: 84976229373     PISSN: 2278330X     EISSN: 22784306     Source Type: Journal    
DOI: 10.4103/2278-330X.155693     Document Type: Conference Paper

References (10)

1. Häussler O, Epstein JI, Amin MB, Heitz PU, Hailemariam S. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer. Hum Pathol 1999;30:1077-86.
2. Kallakury BV, Figge J, Ross JS, Fisher HA, Figge HL, Jennings TA. Association of p53 immunoreactivity with high Gleason tumor grade in prostatic adenocarcinoma. Hum Pathol 1994;25:92-7.
3. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, et al. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 1993;85:1657-69.
4. Tamboli P, Amin MB, Xu HJ, Linden MD. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: Comparison with prostatic adenocarcinoma and benign prostate. Mod Pathol 1998;11:247-52.
5. Yang G, Stapleton AM, Wheeler TM, Truong LD, Timme TL, Scardino PT, et al. Clustered p53 immunostaining: A novel pattern associated with prostate cancer progression. Clin Cancer Res 1996;2:399-401.
6. Koivisto P, Visakorpi T, Rantala I, Isola J. Increased cell proliferation activity and decreased cell death are associated with the emergence of hormone-refractory recurrent prostate cancer. J Pathol 1997;183:51-6.
7. Voelkel-Johnson C, Voeks DJ, Greenberg NM, Barrios R, Maggouta F, Kurtz DT, et al. Genomic instability-based transgenic models of prostate cancer. Carcinogenesis 2000;21:1623-7.
8. Stapleton AM, Zbell P, Kattan MW, Yang G, Wheeler TM, Scardino PT, et al. Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery. Cancer 1998;82:168-75.
9. Staunton MJ, Gaffney EF. Apoptosis: Basic concepts and potential significance in human cancer. Arch Pathol Lab Med 1998;122:310-9.
10. Quinn DI, Henshall SM, Head DR, Golovsky D, Wilson JD, Brenner PC, et al. Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy. Cancer Res 2000;60:1585-94.